Native name 参天製薬株式会社 Traded as TYO: 4536OSE: 4536 Headquarters Japan Founded 4 July 1925 | Industry Pharmaceutical Founder Kenkichi Taguchi | |
 | ||
Products PharmaceuticalsMedical devices Stock price 4536 (TYO) JP¥ 1,653 -25.00 (-1.49%)22 Mar, 1:31 PM GMT+9 - Disclaimer CEO Akira Kurokawa (Jun 2008–) Subsidiaries Novagali Pharma S.A., InnFocus, Inc., Santen Oy | ||
Santen Pharmaceutical Co., Ltd. (参天製薬株式会社, Santen Seiyaku Kabushiki-gaisha), is Japanese pharmaceutical company, specializing in ophthalmology and rheumatology medicines. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.
The company was founded in 1890 by Kenkichi Taguchi, as Taguchi Santendo, and in 1925, Santendo Co., Ltd. was established. In 2014 Santen announced that it has entered into an agreement with Merck & Co. to purchase Merck's ophthalmology products.
Business locations
Santen has 3 plants located in Hōdatsushimizu, Ishikawa, in Tampere and in Suzhou, 21 subsidiary companies located in Japan, the US, the Netherlands, Finland, United Kingdom & Ireland, Spain, Switzerland, Italy, France, Germany, Sweden, China, South Korea, Taiwan, India, Thailand, Malaysia, the Philippines and Singapore. Its R&D center is located in Ikoma, Nara.